Mesenchymal stem cell transplantation ameliorates Sjögren’s syndrome via suppressing IL-12 production by dendritic cells

Abstract Background Mesenchymal stem cells (MSCs) have been demonstrated to be effective in treating autoimmune diseases including Sjögren’s syndrome (SS). We aim to compare the effects of MSC transplantation (MSCT) and the role of serum interleukin-12 (IL-12) in SS. Methods IL-12 levels were measur...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Bingyu Shi, Jingjing Qi, Genhong Yao, Ruihai Feng, Zhuoya Zhang, Dandan Wang, Chen Chen, Xiaojun Tang, Liwei Lu, Wanjun Chen, Lingyun Sun
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2018-11-01
Edice:Stem Cell Research & Therapy
Témata:
Mesenchymal stem cells
Sjögren’s syndrome
Interleukin-12
On-line přístup:http://link.springer.com/article/10.1186/s13287-018-1023-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky